2025 年葡萄糖生物感測器全球市場報告

預計未來幾年葡萄糖生物感測器的市場規模將快速成長。到 2029 年，這一數字將成長至 275.4 億美元，複合年成長率為 13.1%。預測期內的成長可歸因於個人化的醫療保健解決方案、糖尿病患者數量的增加、持續血糖監測的擴展、與穿戴式技術的整合以及非侵入性監測的發展。預測期內的主要趨勢包括環保生物感測器設計、互聯互通和資料共用、增強型家庭醫療保健、非侵入性監測技術和可植入生物感測器。

預計未來幾年糖尿病盛行率的上升將推動葡萄糖生物感測器市場的成長。糖尿病是一種慢性疾病，當胰臟無法產生足夠的胰島素或身體無法有效利用產生的胰島素時就會發生。透過使用葡萄糖生物感測器定期監測血糖值，糖尿病患者可以更有效地管理病情並在必要時調整藥物。例如，2024 年 6 月，英國管理機構 NHS England 報告稱，2023 年在 GP 處登記的 3,615,330 人被確診患有非糖尿病性高血糖症（通常稱為糖尿病前期），高於 2022 年的 3,065,825 人，增幅近 18%。因此，糖尿病盛行率的上升是推動葡萄糖生物感測器市場擴張的關鍵因素。

老年人口的增加預計將促進葡萄糖生物感測器市場的成長。老齡化社會的特徵是老年人比例不斷增加，葡萄糖生物感測器可幫助人們透過早期檢測、遠端監控和全面的健康管理來有效管理糖尿病。根據世界衛生組織（WHO）2022年10月的報告，到2030年，全球整體每六人中就有一人年齡超過60歲，到2050年這個年齡層的人口將達到21億人。在英國，根據英國國會下院圖書館2021年6月發布的預測，到2043年老年人口將佔總人口的24%，達到1,740萬人。因此，老年人口的增加是推動葡萄糖生物感測器市場成長的關鍵因素。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第 4 章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球葡萄糖生物感測器市場的 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 最終用途產業分析
• 全球葡萄糖生物感測器市場：成長率分析
• 全球葡萄糖生物感測器市場表現：規模與成長，2019 年至 2024 年
• 全球葡萄糖生物感測器市場預測：規模與成長，2024-2029 年，2034 年
• 全球葡萄糖生物感測器總目標市場 (TAM)

第6章 市場細分

• 全球葡萄糖生物感測器市場按產品類型、性能和預測，2019-2024、2024-2029、2034
• 持續血糖監測
• 自我血糖監測
• 非侵入性血糖監測
• 全球葡萄糖生物感測器市場技術、性能及預測，2019-2024、2024-2029、2034
• 電化學生物感測器
• 光學生物感測器
• 壓電生物感測器
• 其他
• 全球葡萄糖生物感測器市場（按最終用戶、性能和預測），2019-2024 年、2024-2029 年、2034 年
• 醫院
• 居家護理
• 診斷中心和診所
• 其他
• 全球葡萄糖生物感測器市場：持續葡萄糖監測 (CGM) 細分市場（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
• 即時 CGM 系統
• 專業 CGM 系統
• 胰島素幫浦整合
• 感測器類型
• 全球葡萄糖生物感測器市場：自我血糖監測 (SMBG) 細分市場按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 血糖儀
• 測試條
• 血液樣本類型
• 全球葡萄糖生物感測器市場：非侵入式血糖監測細分市場（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
• 光學葡萄糖感測器
• 經皮感應器
• 穿戴式裝置

第7章 區域和國家分析

• 全球葡萄糖生物感測器市場各地區、績效及預測，2019-2024、2024-2029、2034
• 全球葡萄糖生物感測器市場（依國家分類）、績效及預測，2019-2024、2024-2029、2034

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第 17 章 德國市場

第 18 章 法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第 25 章：加拿大市場

第26章 南美洲市場

第 27 章：巴西市場

第28章 中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

• 葡萄糖生物感測器市場：競爭格局
• 葡萄糖生物感測器市場：公司簡介
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • DexCom Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • GlySens Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • Trividia Health Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• Bayer AG
• LifeScan Inc.
• Medtronic plc
• Nova Biomedical Corporation
• Senseonics Holdings
• ACON Laboratories Inc.
• AgaMatrix Inc.
• Ypsomed AG
• Ascencia Diabetes Care Holdings Inc.
• Bio-Rad Laboratories Inc.
• DuPont de Nemours Inc.
• Biosensors International Group Ltd.
• Cytiva
• Universal Biosensors Inc.
• CARDEA BIO INC.

第 32 章 全球市場競爭基準化分析與儀表板

第33章 重大併購

第 34 章 近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029 年葡萄糖生物感測器市場：提供新機會的國家
• 2029 年葡萄糖生物感測器市場：細分市場將帶來新機會
• 2029 年葡萄糖生物感測器市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第 36 章 附錄

A glucose biosensor is a specialized device designed for measuring glucose levels in different samples, commonly found in biological fluids such as blood or interstitial fluid. Widely applied in healthcare, especially for diabetes management, these biosensors facilitate convenient and frequent monitoring of blood glucose levels.

The primary product categories for glucose biosensors include continuous glucose monitoring, self-monitoring blood glucose, and non-invasive glucose monitoring. Continuous glucose monitoring (CGM) involves using a miniature sensor implanted under the skin to measure glucose levels in the patient's body. This method offers a more comprehensive view of glucose levels compared to standard fingerstick glucose monitoring and provides real-time results. The technologies predominantly used are electrochemical biosensors, optical biosensors, piezoelectric biosensors, and others. These biosensors find applications across various end-users such as hospitals, home care, diagnostic centers, clinics, and others.

The glucose biosensors market research report is one of a series of new reports from The Business Research Company that provides glucose biosensors market statistics, including glucose biosensors industry global market size, regional shares, competitors with a glucose biosensors market share, detailed glucose biosensors market segments, market trends and opportunities, and any further data you may need to thrive in the glucose biosensors industry. This glucose biosensors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The glucose biosensors market size has grown rapidly in recent years. It will grow from$15.26 billion in 2024 to $16.85 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to research and development, cost-efficiency, user-friendly design, increasing diabetes prevalence, integration with smart devices, non-invasive monitoring techniques

The glucose biosensors market size is expected to see rapid growth in the next few years. It will grow to $27.54 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to personalized healthcare solutions, rise in diabetes cases, continuous glucose monitoring expansion, integration with wearable tech, non-invasive monitoring development. Major trends in the forecast period include eco-friendly biosensor designs, interconnectivity and data sharing, home healthcare empowerment, non-invasive monitoring techniques, implantable biosensors.

The increasing prevalence of diabetes is projected to drive the growth of the glucose biosensors market in the coming years. Diabetes is a chronic condition that occurs when the pancreas does not produce sufficient insulin or when the body is unable to effectively use the insulin produced. Patients with diabetes rely on glucose biosensors to regularly monitor their blood glucose levels, allowing them to manage their condition more effectively and adjust their medication as needed. For example, in June 2024, NHS England, a governing body in the UK, reported that in 2023, 3,615,330 individuals registered with a GP were identified as having non-diabetic hyperglycemia, commonly known as pre-diabetes, which reflects an increase from 3,065,825 in 2022-an almost 18% rise. Therefore, the growing prevalence of diabetes is a significant factor driving the expansion of the glucose biosensors market.

The increasing aging population is anticipated to contribute to the growth of the glucose biosensor market. The aging population, characterized by a rising proportion of elderly individuals, benefits from glucose biosensors that support effective diabetes management through early detection, remote monitoring, and overall well-being. According to the World Health Organization's October 2022 report, globally, one in six people will be 60 or older by 2030, with the number of individuals in this age group reaching 2.1 billion by 2050. In the United Kingdom, projections from the UK Parliament's House of Commons Library in June 2021 indicate that by 2043, the senior population will constitute 24% of the total population, amounting to 17.4 million people. Therefore, the growing aging population is a significant factor driving the growth of the glucose biosensor market.

Leading companies in the glucose biosensor market are concentrating on innovative product launches, particularly glucose monitoring systems, to assist individuals with diabetes. These systems are designed to continuously measure and provide real-time data on blood glucose levels, helping individuals manage their condition more effectively. For instance, in October 2024, DexCom Inc., a biotechnology company based in the United States, introduced the Stelo Glucose Biosensor System. This system is notable for being the first over-the-counter (OTC) continuous glucose monitor (CGM) approved by the U.S. Food and Drug Administration (FDA). The Stelo system is intended for adults aged 18 and older who do not use insulin, including those with Type 2 diabetes or prediabetes. It can also be utilized by individuals without diabetes who want to monitor their glucose levels to better understand how their diet and exercise impact blood sugar.

Major companies in the glucose biosensor market are emphasizing innovative product launches, exemplified by the introduction of the GlucoMen Day continuous glucose monitoring (CGM) system, to diversify their product portfolio and broaden market outreach. The GlucoMen Day CGM system, a real-time subcutaneous continuous glucose monitoring system, is designed to assist individuals with diabetes in effectively managing their blood sugar levels. This system offers a more convenient and accurate alternative for tracking glucose fluctuations compared to traditional finger-pricking methods. In April 2022, 77 Elektronika Kft., a Hungary-based medical equipment manufacturer, introduced the glucomen day continuous glucose monitoring (CGM) system in collaboration with A. Menarini Diagnostics, an Italy-based diagnostics company. The glucomen day CGM system represents a notable advancement in diabetes management technology, providing users with valuable insights into their glucose levels and empowering them to make informed decisions for better diabetes control. This innovative system has the potential to enhance the quality of life for people with diabetes and alleviate the burden of this chronic condition.

In May 2023, Medtronic plc, an Ireland-based medical device company, completed the acquisition of EOFLOW Co., Ltd. for $738 million. Through this strategic acquisition, Medtronic plc aims to broaden treatment options, cater to the demand for discreet delivery, and strengthen its position in the market. EOFLOW Co. Ltd. is a South Korea-based medical device company specialized in developing and manufacturing wearable drug delivery systems.

Major companies operating in the glucose biosensors market include Abbott Laboratories, DexCom Inc., F. Hoffmann-La Roche AG, GlySens Incorporated, Trividia Health, Bayer AG, LifeScan Inc., Medtronic plc, Nova Biomedical Corporation, Senseonics Holdings, ACON Laboratories Inc., AgaMatrix Inc., Ypsomed AG, Ascencia Diabetes Care Holdings Inc., Bio-Rad Laboratories Inc., DuPont de Nemours Inc., Biosensors International Group Ltd., Cytiva, Universal Biosensors Inc., CARDEA BIO INC., Conductive Technologies Inc., EarlySense Inc., Innovative Sensor Technology IST AG, LifeSignals Inc., NeuroSky Inc., SD Biosensor INC., Xsensio, Taidoc Technology Corporation

North America was the largest region in the glucose biosensors market in 2024. The regions covered in the glucose biosensors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the glucose biosensors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The glucose biosensors market consists of sales of magnetic biosensors, thermometric biosensors, potentiometric, amperometric, and conductometric sensors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Glucose Biosensors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on glucose biosensors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for glucose biosensors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The glucose biosensors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Continuous Glucose Monitoring; Self-monitoring Blood Glucose; Non-invasive Glucose Monitoring
• 2) By Technology: Electrochemical Biosensors; Optical Biosensors; Piezoelectric Biosensors; Others Technologies
• 3) By End Users: Hospitals; Home Care; Diagnostic Centers and Clinics; Other End Users
• Subsegments:
• 1) By Continuous Glucose Monitoring (CGM): Real-time CGM systems; Professional CGM systems; Integration with insulin pumps; Sensor types
• 2) By Self-monitoring Blood Glucose (SMBG): Glucometers; Test strips; Blood sample types
• 3) By Non-invasive Glucose Monitoring: Optical glucose sensors; Transdermal sensors; Wearable devices
• Companies Mentioned: Abbott Laboratories; DexCom Inc.; F. Hoffmann-La Roche AG; GlySens Incorporated; Trividia Health
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Glucose Biosensors Market Characteristics

3. Glucose Biosensors Market Trends And Strategies

4. Glucose Biosensors Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Glucose Biosensors Growth Analysis And Strategic Analysis Framework

• 5.1. Global Glucose Biosensors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Glucose Biosensors Market Growth Rate Analysis
• 5.4. Global Glucose Biosensors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Glucose Biosensors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Glucose Biosensors Total Addressable Market (TAM)

6. Glucose Biosensors Market Segmentation

• 6.1. Global Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Continuous Glucose Monitoring
• Self-monitoring Blood Glucose
• Non-invasive Glucose Monitoring
• 6.2. Global Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Electrochemical Biosensors
• Optical Biosensors
• Piezoelectric Biosensors
• Other Technologies
• 6.3. Global Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Home Care
• Diagnostic Centers and Clinics
• Other End Users
• 6.4. Global Glucose Biosensors Market, Sub-Segmentation Of Continuous Glucose Monitoring (CGM), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Real-time CGM systems
• Professional CGM systems
• Integration with insulin pumps
• Sensor types
• 6.5. Global Glucose Biosensors Market, Sub-Segmentation Of Self-monitoring Blood Glucose (SMBG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glucometers
• Test strips
• Blood sample types
• 6.6. Global Glucose Biosensors Market, Sub-Segmentation Of Non-invasive Glucose Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Optical glucose sensors
• Transdermal sensors
• Wearable devices

7. Glucose Biosensors Market Regional And Country Analysis

• 7.1. Global Glucose Biosensors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Glucose Biosensors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Glucose Biosensors Market

• 8.1. Asia-Pacific Glucose Biosensors Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Glucose Biosensors Market

• 9.1. China Glucose Biosensors Market Overview
• 9.2. China Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Glucose Biosensors Market

• 10.1. India Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Glucose Biosensors Market

• 11.1. Japan Glucose Biosensors Market Overview
• 11.2. Japan Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Glucose Biosensors Market

• 12.1. Australia Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Glucose Biosensors Market

• 13.1. Indonesia Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Glucose Biosensors Market

• 14.1. South Korea Glucose Biosensors Market Overview
• 14.2. South Korea Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Glucose Biosensors Market

• 15.1. Western Europe Glucose Biosensors Market Overview
• 15.2. Western Europe Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Glucose Biosensors Market

• 16.1. UK Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Glucose Biosensors Market

• 17.1. Germany Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Glucose Biosensors Market

• 18.1. France Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Glucose Biosensors Market

• 19.1. Italy Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Glucose Biosensors Market

• 20.1. Spain Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Glucose Biosensors Market

• 21.1. Eastern Europe Glucose Biosensors Market Overview
• 21.2. Eastern Europe Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Glucose Biosensors Market

• 22.1. Russia Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Glucose Biosensors Market

• 23.1. North America Glucose Biosensors Market Overview
• 23.2. North America Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Glucose Biosensors Market

• 24.1. USA Glucose Biosensors Market Overview
• 24.2. USA Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Glucose Biosensors Market

• 25.1. Canada Glucose Biosensors Market Overview
• 25.2. Canada Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Glucose Biosensors Market

• 26.1. South America Glucose Biosensors Market Overview
• 26.2. South America Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Glucose Biosensors Market

• 27.1. Brazil Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Glucose Biosensors Market

• 28.1. Middle East Glucose Biosensors Market Overview
• 28.2. Middle East Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Glucose Biosensors Market

• 29.1. Africa Glucose Biosensors Market Overview
• 29.2. Africa Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Glucose Biosensors Market Competitive Landscape And Company Profiles

• 30.1. Glucose Biosensors Market Competitive Landscape
• 30.2. Glucose Biosensors Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. DexCom Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GlySens Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Trividia Health Overview, Products and Services, Strategy and Financial Analysis

31. Glucose Biosensors Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. LifeScan Inc.
• 31.3. Medtronic plc
• 31.4. Nova Biomedical Corporation
• 31.5. Senseonics Holdings
• 31.6. ACON Laboratories Inc.
• 31.7. AgaMatrix Inc.
• 31.8. Ypsomed AG
• 31.9. Ascencia Diabetes Care Holdings Inc.
• 31.10. Bio-Rad Laboratories Inc.
• 31.11. DuPont de Nemours Inc.
• 31.12. Biosensors International Group Ltd.
• 31.13. Cytiva
• 31.14. Universal Biosensors Inc.
• 31.15. CARDEA BIO INC.

32. Global Glucose Biosensors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Glucose Biosensors Market

34. Recent Developments In The Glucose Biosensors Market

35. Glucose Biosensors Market High Potential Countries, Segments and Strategies

• 35.1 Glucose Biosensors Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Glucose Biosensors Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Glucose Biosensors Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer